Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Transcranial photobiomodulation: an emerging therapeutic method to enhance brain bioenergetics
    Published on 2024-07-18
    1 year ago
  • Biomarker development for menstrual cycle affective change: the need for greater temporal, mechanistic, and phenotypic specificity
    Published on 2024-07-18
    1 year ago
  • Is treatment-resistant schizophrenia a neuroimmune condition? Meta-analytic evidence from magnetic resonance spectroscopy
    Published on 2024-07-18
    1 year ago
  • Acute, chronic and conditioned effects of intranasal oxytocin in the mu-opioid receptor knockout mouse model of autism: Social context matters
    Published on 2024-07-17
    1 year ago
  • Rewiring the brain: Inflammation’s impact on glutamate and neural networks in depression
    Published on 2024-07-17
    1 year ago
  • Virtual reality exposure therapy advances and potential for clinical and experimental use
    Published on 2024-07-17
    1 year ago
  • Pump the brakes: identifying neurobiological targets to enhance inhibitory control in drug addiction
    Published on 2024-07-17
    1 year ago
« Previous 1 … 52 53 54 55 56 … 143 Next »
Journal of Psychopharmacology
  • We need to talk: The urgent conversation on chronic pain, mental health, prescribing patterns and the opioid crisis
    Published on 2023-02-22
    3 years ago
  • Clozapine rechallenge or continuation despite neutropenia or agranulocytosis using colony-stimulating factor: A systematic review
    Published on 2023-02-16
    3 years ago
  • Associations of antidepressants and antipsychotics with lipid parameters: Do CYP2C19/CYP2D6 genes play a role? A UK population-based study
    Published on 2023-02-11
    3 years ago
  • A phase 1b study to investigate the potential interactions between ASP8062 and buprenorphine/naloxone in patients with opioid use disorder
    Published on 2023-02-04
    3 years ago
  • Comparison of locomotor stimulant and drug discrimination effects of four synthetic cathinones to commonly abused psychostimulants
    Published on 2023-02-04
    3 years ago
  • Co-medication with disulfiram markedly increased serum clozapine levels: Two case reports
    Published on 2023-01-27
    3 years ago
  • The D1/D2-like receptor antagonist flupentixol and the D2-like receptor antagonist L-741626 decrease operant responding for nicotine and food and locomotor activity in male and female rats
    Published on 2023-01-21
    3 years ago
« Previous 1 … 52 53 54 55 56 … 134 Next »
European Neuropsychopharmacology
  • The impact of the COVID-19 pandemic on ADHD medicine consumption in 47 countries and regions
    Published on 2023-04-17
    3 years ago
  • Antidepressant efficacy of cariprazine in bipolar disorder and the role of its pharmacodynamic properties: A hypothesis based on data
    Published on 2023-04-14
    3 years ago
  • Inflammatory disequilibrium and lateral ventricular enlargement in treatment-resistant schizophrenia
    Published on 2023-04-13
    3 years ago
  • Psychotropic drugs consumption during 2020 COVID-19 pandemic and lockdowns: Evidence of a surprising resilience of the drugs delivery system in France.
    Published on 2023-04-11
    3 years ago
  • Kappa opioid activation changes protein profiles in different regions of the brain relevant to depression
    Published on 2023-04-09
    3 years ago
  • Intranasal administration of olanzapine has beneficial outcome in a rat activity-based anorexia model
    Published on 2023-04-08
    3 years ago
  • Repurposing selective serotonin reuptake inhibitors for severity of COVID-19: a population-based study
    Published on 2023-04-05
    3 years ago
« Previous 1 … 52 53 54 55 56 … 154 Next »

   Pharma Pub